A 63-year-old woman with type 2 diabetes for 8 years and coronary artery disease has HbA1c 7.8% (0.62) on metformin and gliclazide. BMI is 32 kg/m², e...

Question

A 63-year-old woman with type 2 diabetes for 8 years and coronary artery disease has HbA1c 7.8% (0.62) on metformin and gliclazide. BMI is 32 kg/m², eGFR 72 mL/min/1.73 m². According to Diabetes Canada, which change best improves cardiovascular risk?

Accepted Answer

Add an SGLT2 inhibitor

Answer

Increase gliclazide dose to maximum

Answer

Switch metformin to basal insulin

Answer

Add acarbose

Answer

Stop metformin and use lifestyle alone

ca-mccqe1 MCQ (SBA): Type 2 diabetes with cardiovascular disease

A 63-year-old woman with type 2 diabetes for 8 years and coronary artery disease has HbA1c 7.8% (0.62) on metformin and gliclazide. BMI is 32 kg/m², eGFR 72 mL/min/1.73 m². According to Diabetes Canada, which change best improves cardiovascular risk?